Biologics represented 5% of the drugs prescribed in the U.S. in 2024, but they accounted for more than half of the country’s ...

FDA aims to speed biosimilar approvals to increase competition, but experts warn drug prices may not drop quickly.

If you have chronic spontaneous urticaria (CSU) and treatments like antihistamines and steroids aren’t helping, medicines called biologics might be a good choice for you. Biologics are medicines that ...

The Food and Drug Administration (FDA) is launching an effort to streamline the approval process for cheaper alternative “biosimilar” versions of biologic drugs as a way to curb health costs. The ...

We live in a world where computers can power the entire world wide web, create music and art, and even write college essays. But when it comes to taming biology, we have not been able to take full ...

Please provide your email address to receive an email when new articles are posted on . Dupilumab received FDA approval for treating adults with poorly controlled COPD with type 2 inflammation in ...

Among patients with inflammatory bowel disease (IBD), overlapping biologic therapy was common during medication switches and was not associated with a higher risk for infection than nonoverlapping ...

Panelists discuss how key biologic and clinical distinctions—such as ischemia, leakage patterns, and modality-specific ...